MD Anderson, AstraZeneca enter collaboration to help improve patient outcomes in ovarian and gynecologic cancers
Collaboration draws on expertise from MD Anderson’s Moon Shots Program
MD Anderson News Release 01/29/2015
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
The agreement represents...
MD Anderson and Bayer announce collaboration to create symptom assessment questionnaires in clinical trials
MD Anderson News Release 1/23/2015
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians...
MD Anderson receives top Chinese science and technology award
MD Anderson News Release 01/16/2015
The University of Texas MD Anderson Cancer Center was presented the People’s Republic of China...
MD Anderson presents 10th Making Cancer History® Seminar in West Palm Beach
Experts reveal latest knowledge in breast and prostate cancers, prevention
MD Anderson News Release 01/15/2015
Renowned oncologists from The University of Texas MD Anderson Cancer Center return to West Palm Beach Jan. 31 for the institution’s well-known Making Cancer History® educational seminar. Doctors will discuss their innovative research in breast and prostate cancers, share vital cancer prevention tips and...
MD Anderson study finds patients with metastatic colorectal cancer having less surgery, yet survival rates improving
Researchers still question if primary tumor resection is overused in patient population
MD Anderson News Release 01/14/2015
With...
Intrexon, ZIOPHARM and MD Anderson in Exclusive CAR T Pact
Exclusive licensing agreement for CAR T Cell, TCR, NK cell programs and associated technologies for the development of non-viral adoptive...
MD Anderson and Amgen announce agreement to develop BiTE® therapies for myelodysplastic syndrome
MD Anderson’s Moon Shots program key to collaboration
MD Anderson News Release 01/12/2015
The University of Texas MD Anderson...
Novel Anti-Cancer Drug, ONC201, Focus of Alliance Between Oncoceutics and MD Anderson
MD Anderson News Release 01/05/2015
Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation...